VIVUS Press Releases

Date Title Links
Toggle Summary VIVUS to Present at BIO CEO & Investor Conference
VIVUS to Present at BIO CEO & Investor Conference MOUNTAIN VIEW, Calif., Feb. 10 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS), a leading specialty pharmaceutical company focused on the development and commercialization of novel products to restore sexual function in women and men, today
View HTML
Toggle Summary VIVUS Announces FDA Acceptance of EvaMist(TM) NDA Submission
EvaMist(TM) is an Investigational Drug for the Treatment of Menopausal Symptoms
View HTML